Market Overview

Accelr8 Attracts Up To $35 Million Private Equity Investment

Accelr8 Technology Corporation (NYSE: AXK) announced today that an investment group formed by Jack Schuler, John Patience, and Larry Mehren will invest a total of up to $35 million in Accelr8's common stock. The purpose is to complete the product development and market introduction of Accelr8's BACcelâ„¢ culture-free, diagnostic system for same-shift identification and antibiotic resistance testing of bacterial and fungal pathogens.

Jack Schuler and John Patience are the principals and founders of Crabtree Partners LLC. Crabtree has been instrumental in the success of numerous companies including founding Stericycle, and leading the investment group that provided the capital for Ventana Medical Systems' first instrument. As Chairman and Vice-Chairman for over ten years, Jack Schuler and John Patience were instrumental in the growth of both organizations, resulting in the successful sale of Ventana to Roche for $3.4B, and the growth of Stericycle's current market capitalization to over $7.4B.

Posted-In: News Contracts

 

Most Popular

Related Articles (AXK)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free